Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
09/26/2000 | US6124104 Chromosome 13-linked breast cancer susceptibility gene |
09/26/2000 | US6124101 Diagnosis of thrombosis in a mammals; incubating a sample of fluid with an antibody that preferentially binds a cleaved activation peptide, counting antibody bound cleaved activation peptides, compare to control |
09/26/2000 | US6123941 Method for restoration of normal phenotype in cancer cells |
09/26/2000 | US6123938 Human urinary hyaluronidase |
09/26/2000 | US6123860 Method for separating cell populations by thermophilic characteristics |
09/26/2000 | CA2283470A1 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
09/26/2000 | CA1341101C Recombinant c-terminal .alpha.- amidating enzyme |
09/25/2000 | CA2301257A1 The ire gene regulating the root-hair growth in arabidopsis |
09/21/2000 | WO2000055621A2 Blood leucocyte apheresis for treatment of disease |
09/21/2000 | WO2000055373A2 Methods of screening for macrophage development modulators |
09/21/2000 | WO2000055371A1 27 human secreted proteins |
09/21/2000 | WO2000055355A2 Method of screening candidate compounds for susceptibility to biliary excretion |
09/21/2000 | WO2000055352A2 50 human secreted proteins |
09/21/2000 | WO2000055351A1 Human colon cancer associated gene sequences and polypeptides |
09/21/2000 | WO2000055350A1 Human cancer associated gene sequences and polypeptides |
09/21/2000 | WO2000055345A2 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
09/21/2000 | WO2000055343A2 Retrovirus producting cells utilizing a high multiplicity of transduction |
09/21/2000 | WO2000055342A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
09/21/2000 | WO2000055337A1 Transgenic plants that are resistant to a broad spectrum of pathogens |
09/21/2000 | WO2000055332A2 Human regulators of intracellular phosphorylation |
09/21/2000 | WO2000055326A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
09/21/2000 | WO2000055325A2 Plant centromeres |
09/21/2000 | WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof |
09/21/2000 | WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
09/21/2000 | WO2000055318A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
09/21/2000 | WO2000055312A2 Rt-pcr of clonal neurospheres |
09/21/2000 | WO2000055310A1 Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
09/21/2000 | WO2000055306A1 Cells, cell populations, and methods of making and using same |
09/21/2000 | WO2000055305A1 Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides |
09/21/2000 | WO2000055302A2 Genetically modified plants having modulated brassinosteroid signaling |
09/21/2000 | WO2000055300A1 Method for preparing porous, biodegradable and biocompatible, polymeric scaffolds for tissue engineering |
09/21/2000 | WO2000055207A1 A novel chimeric protein for prevention and treatment of hiv infection |
09/21/2000 | WO2000055205A1 ISOFORMS OF MOUSE SEROTONIN 5-HT2c RECEPTOR |
09/21/2000 | WO2000055201A1 49 human secreted proteins |
09/21/2000 | WO2000055200A1 50 human secreted proteins |
09/21/2000 | WO2000055199A1 47 human secreted proteins |
09/21/2000 | WO2000055198A1 50 human secreted proteins |
09/21/2000 | WO2000055194A2 Tuberculosis antigens and methods of use therefor |
09/21/2000 | WO2000055180A2 Human lung cancer associated gene sequences and polypeptides |
09/21/2000 | WO2000055178A1 INSECT p53 TUMOR SUPPRESSOR GENES AND PROTEINS |
09/21/2000 | WO2000055177A2 49 human secreted proteins |
09/21/2000 | WO2000055176A2 49 human secreted proteins |
09/21/2000 | WO2000055175A1 50 human secreted proteins |
09/21/2000 | WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides |
09/21/2000 | WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides |
09/21/2000 | WO2000055171A1 50 human secreted proteins |
09/21/2000 | WO2000055169A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
09/21/2000 | WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
09/21/2000 | WO2000054802A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
09/21/2000 | WO2000054796A1 Novel antiangiogenic peptides |
09/21/2000 | WO2000054583A1 Methods for culturing fluid-filled sensory organs |
09/21/2000 | WO2000054580A2 Leukotriene b4 receptor transgenic mammals |
09/21/2000 | WO2000040739A3 RIBONUCLEOTIDE REDUCTASE LARGE SUBUNIT (R1) cDNA AND USES THEREOF |
09/21/2000 | WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy |
09/21/2000 | WO2000039292A3 Antisense oligonucleotide for inhibiting the expression of the adhesion molecule very late antigen 4 (vla-4) in human cells |
09/21/2000 | WO2000027868A3 Connective tissue growth factor (ctgf) and methods of use |
09/21/2000 | WO2000027207A8 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
09/21/2000 | WO2000026237A3 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
09/21/2000 | WO2000026227A9 Ldl related protein and uses thereof |
09/21/2000 | WO2000020598A9 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
09/21/2000 | WO2000020574A3 Fusions of scaffold proteins with random peptide libraries |
09/21/2000 | WO2000020039A9 Methods and adjuvants for stimulating mucosal immunity |
09/21/2000 | WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization |
09/21/2000 | WO2000007427A3 Method for selective and optionally reversible degeneration of somatic plant tissue |
09/21/2000 | DE19919806A1 Carrier for extracting bacteria comprises a porous material |
09/21/2000 | DE19918023A1 Preparation of a liver cell-derived packaging cell line comprises stabile transfection of adenoviral E1 sequences of human hepatoma cells |
09/21/2000 | CA2376798A1 Novel methods of diagnosing macrophage development related disorders, compositions, and methods of screening for macrophage development modulators |
09/21/2000 | CA2368068A1 27 human secreted proteins |
09/21/2000 | CA2367906A1 Tcl-1b gene and protein and related methods and compositions |
09/21/2000 | CA2367357A1 Method |
09/21/2000 | CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
09/21/2000 | CA2367213A1 Novel antiangiogenic peptides |
09/21/2000 | CA2367160A1 Leukotriene b4 receptor transgenic mammals |
09/21/2000 | CA2366929A1 Making and using microclonal uncloned cdna libraries |
09/21/2000 | CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
09/21/2000 | CA2366174A1 Human colon cancer associated gene sequences and polypeptides |
09/21/2000 | CA2366130A1 Human cancer associated gene sequences and polypeptides |
09/21/2000 | CA2365655A1 Retrovirus producting cells utilizing a high multiplicity of transduction |
09/21/2000 | CA2365645A1 Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
09/21/2000 | CA2365398A1 Method of screening candidate compounds for susceptibility to biliary excretion |
09/21/2000 | CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
09/21/2000 | CA2364739A1 Regulators of intracellular phosphorylation |
09/21/2000 | CA2364650A1 50 human secreted proteins |
09/21/2000 | CA2364637A1 50 human secreted proteins |
09/21/2000 | CA2364635A1 47 human secreted proteins |
09/21/2000 | CA2364630A1 50 human secreted proteins |
09/21/2000 | CA2364629A1 Human lung cancer associated gene sequences and polypeptides |
09/21/2000 | CA2364590A1 Human prostate cancer associated gene sequences and polypeptides |
09/21/2000 | CA2364549A1 50 human secreted proteins |
09/21/2000 | CA2363022A1 49 human secreted proteins |
09/21/2000 | CA2363019A1 49 human secreted proteins |
09/21/2000 | CA2362897A1 Plant centromeres |
09/21/2000 | CA2361277A1 49 human secreted proteins |
09/20/2000 | EP1036845A2 Downstream genes of tumor suppressor WT1 |
09/20/2000 | EP1036842A2 Use of cyanobacterial fructose-1,6-bisphosphatase to improve growth of plants |
09/20/2000 | EP1036327A2 Hla-e binding |
09/20/2000 | EP1036195A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof |
09/20/2000 | EP1036186A1 Ribozymes capable of conferring resistance to potyvirus infection, and plants expressing said ribozymes |
09/20/2000 | EP1036185A1 Proteinase inhibitor fusion proteins |
09/20/2000 | EP1036182A1 Method and means for producing high titer, safe, recombinant lentivirus vectors |